Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TRVI | Trevi Therapeutics, Inc. | Chief Financial Officer | $141K | -$11.5K | -7.55% | May 22, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|